Herbal simulation of ephedrine and caffeine in treatment of obesity

[1]  C. Boozer,et al.  Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial , 2002, International Journal of Obesity.

[2]  F. Greenway.  The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent , 2001, Obesity Reviews.

[3]  S. Heymsfield,et al.  An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial , 2001, International Journal of Obesity.

[4]  N. Benowitz,et al.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids , 2000 .

[5]  D. Molnár,et al.  Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents , 2000, International Journal of Obesity.

[6]  J. Rood,et al.  Pharmaceutical cost savings of treating obesity with weight loss medications. , 1999, Obesity research.

[7]  A. Dulloo,et al.  Adaptive reduction in basal metabolic rate in response to food deprivation in humans: a role for feedback signals from fat stores. , 1998, The American journal of clinical nutrition.

[8]  J. Ingerslev,et al.  Is an ephedrine caffeine treatment contraindicated in hypertension? , 1997, International Journal of Obesity.

[9]  A. Dulloo,et al.  Poststarvation hyperphagia and body fat overshooting in humans: a role for feedback signals from lean and fat tissues. , 1997, The American journal of clinical nutrition.

[10]  R. Atkinson,et al.  Combined drug treatment of obesity. , 1995, Obesity research.

[11]  A. Astrup,et al.  The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[12]  A. Dulloo.  Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[13]  R. Pasquali,et al.  Clinical aspects of ephedrine in the treatment of obesity. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[14]  S. Toubro,et al.  The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. , 1992, Metabolism: clinical and experimental.

[15]  S. Toubro,et al.  The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[16]  B. Ransil,et al.  Ephedrine, caffeine and aspirin promote weight loss in obese subjects. , 1990, Transactions of the Association of American Physicians.

[17]  T. Maher,et al.  Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat. , 1987, Journal of pharmaceutical sciences.

[18]  P. Hess.  Management of obesity. , 1961, Pediatric clinics of North America.